Clear Harbor Asset Management LLC Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Clear Harbor Asset Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,497 shares of the healthcare conglomerate’s stock after selling 114 shares during the quarter. Clear Harbor Asset Management LLC’s holdings in UnitedHealth Group were worth $4,473,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Moneta Group Investment Advisors LLC raised its holdings in shares of UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after purchasing an additional 11,812,017 shares during the period. Norges Bank acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $5,210,004,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of UnitedHealth Group by 1,682.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after purchasing an additional 2,540,538 shares during the last quarter. Barclays PLC increased its position in UnitedHealth Group by 143.4% in the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock worth $1,679,401,000 after buying an additional 2,058,829 shares during the period. Finally, Morgan Stanley grew its position in shares of UnitedHealth Group by 13.8% during the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after acquiring an additional 1,893,192 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have commented on UNH. Truist Financial restated a “buy” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Thursday, November 30th. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Bank of America reissued a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Royal Bank of Canada reiterated an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Finally, Barclays began coverage on shares of UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price objective for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $579.33.

UnitedHealth Group Trading Up 0.3 %

UNH traded up $1.60 during trading on Thursday, reaching $494.70. The company had a trading volume of 3,805,551 shares, compared to its average volume of 4,097,774. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $554.70. The firm’s 50-day simple moving average is $503.10 and its 200 day simple moving average is $518.61. The company has a market cap of $456.08 billion, a price-to-earnings ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company’s revenue was up 14.1% on a year-over-year basis. During the same quarter last year, the business posted $5.34 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is 31.54%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.